ArticleNeuro-oncology advances

WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models.

Jason E Conage-Pough et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.